ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 146 filers reported holding ITEOS THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.79 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $3,580,966 | -70.3% | 241,305 | -72.7% | 0.00% | -60.0% |
| Q1 2024 | $12,043,861 | +13.7% | 882,981 | -8.7% | 0.01% | 0.0% |
| Q4 2023 | $10,593,052 | -6.3% | 967,402 | -6.3% | 0.01% | -16.7% |
| Q3 2023 | $11,309,664 | +3.4% | 1,032,846 | +25.0% | 0.01% | +20.0% |
| Q2 2023 | $10,937,590 | +152022.3% | 826,102 | +56.4% | 0.01% | +25.0% |
| Q1 2023 | $7,190 | -60.2% | 528,272 | -42.9% | 0.00% | -60.0% |
| Q4 2022 | $18,056 | -99.9% | 924,480 | +25.2% | 0.01% | +25.0% |
| Q3 2022 | $14,066,000 | +110.3% | 738,356 | +127.4% | 0.01% | +100.0% |
| Q2 2022 | $6,689,000 | -29.5% | 324,697 | +10.1% | 0.00% | -20.0% |
| Q1 2022 | $9,489,000 | -10.4% | 294,860 | +29.6% | 0.01% | 0.0% |
| Q4 2021 | $10,589,000 | +3880.8% | 227,436 | +2089.2% | 0.01% | – |
| Q2 2021 | $266,000 | -46.7% | 10,389 | -28.8% | 0.00% | – |
| Q1 2021 | $499,000 | -6.7% | 14,593 | -7.7% | 0.00% | – |
| Q4 2020 | $535,000 | – | 15,809 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,738,785 | $29,989,696 | 14.74% |
| MPM BioImpact LLC | 1,745,943 | $19,118,076 | 4.47% |
| Saturn V Capital Management LP | 828,232 | $9,069,140 | 3.47% |
| SECTORAL ASSET MANAGEMENT INC | 220,056 | $2,409,613 | 1.04% |
| Boxer Capital, LLC | 1,804,058 | $19,754,435 | 0.98% |
| RA Capital Management | 4,417,259 | $48,368,986 | 0.76% |
| 683 Capital Management, LLC | 715,000 | $7,829,249 | 0.64% |
| Ikarian Capital, LLC | 346,471 | $3,793,857 | 0.36% |
| BVF INC/IL | 1,259,476 | $13,791,262 | 0.34% |
| EcoR1 Capital, LLC | 1,115,022 | $12,209,491 | 0.32% |